Tolero Pharmaceuticals Home
Making Meaningful Medicines
Tolero Pharmaceuticals, Inc.,
a clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases.
clear space
Tolero Pharmaceuticals' Alvocidib Selected as 'Top 10 Most Interesting Oncology Project... Line Tolero Pharmaceuticals Presents Positive Preclinical Data... Line Tolero Pharmaceuticals Completes Second Tranche of Series B Financing Line Tolero Pharmaceuticals Closes $14.2 Million Series B Financing Line Tolero Pharmaceuticals, Inc. Presents Positive Interim Phase 2 Clinical Trial Results...

Tolero Pharmaceuticals

Tolero PharmaceuticalsTolero Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to alleviating human suffering through the discovery and development of novel therapeutics to treat cancer and other serious human diseases. Our pipeline targets important biological drivers of blood disorders to treat leukemias and anemia. MORE
Researchers
Learn how Tolero researchers are actively expanding scientific understanding of hematological disease. MORE
Patients
See how clinical trials on the use of Alvocidib to treat acute myeloid leukemia (AML) are demonstrating promising results. MORE
Investors
Find out how Tolero's pipeline agents offer tremendous opportunities for investors. MORE
clear space